Basic Information
RNALocate ID: | RLID:11003599 |
RNA Symbol: | hsa-miR-28-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-28-3p |
RNA ID: | miRBase:MIMAT0004502 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002574 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002575 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002576 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11003598 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11003600 | Microvesicle | Seminal plasma | 23539611 |
RLID:11003601 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000179 | Exosome | Blood|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000582 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-28-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34001 |
MNDR | hsa-miR-28-3p | Lymphoma | MNDR-E-MI-34002 |
MNDR | hsa-miR-28-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34003 |
MNDR | hsa-miR-28-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34004 |
MNDR | hsa-miR-28-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34005 |
MNDR | hsa-miR-28-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34006 |
MNDR | hsa-miR-28-3p | Breast cancer luminal | MNDR-E-MI-34007 |
MNDR | hsa-miR-28-3p | Prostate cancer | MNDR-E-MI-34008 |
MNDR | hsa-miR-28-3p | Gastric cancer | MNDR-E-MI-34009 |
MNDR | hsa-miR-28-3p | Alzheimer disease | MNDR-E-MI-34010 |
MNDR | hsa-miR-28-3p | Intracranial aneurysm | MNDR-E-MI-34011 |
MNDR | hsa-miR-28-3p | Bladder cancer | MNDR-E-MI-34012 |
MNDR | hsa-miR-28-3p | Esophageal carcinoma | MNDR-E-MI-34013 |
MNDR | hsa-miR-28-3p | Dysautonomia familial | MNDR-E-MI-34014 |
MNDR | hsa-miR-28-3p | Huntington disease | MNDR-E-MI-34015 |
MNDR | hsa-miR-28-3p | Cardiovascular disease | MNDR-E-MI-34016 |
MNDR | hsa-miR-28-3p | Lung cancer | MNDR-E-MI-34017 |
MNDR | hsa-miR-28-3p | Parkinson disease | MNDR-E-MI-34018 |
MNDR | hsa-miR-28-3p | Breast cancer | MNDR-E-MI-34019 |
MNDR | hsa-miR-28-3p | Neuroendocrine neoplasia | MNDR-E-MI-34020 |
MNDR | hsa-miR-28-3p | Pancreatic cancer | MNDR-E-MI-34021 |
MNDR | hsa-miR-28-3p | Rectum adenocarcinoma | MNDR-E-MI-34022 |
MNDR | hsa-miR-28-3p | Nephroblastoma | MNDR-E-MI-34023 |
MNDR | hsa-miR-28-3p | Colon cancer | MNDR-E-MI-34024 |
MNDR | hsa-miR-28-3p | Ischemic attack transient | MNDR-E-MI-34025 |
MNDR | hsa-miR-28-3p | Colon adenocarcinoma | MNDR-E-MI-34026 |
MNDR | hsa-miR-28-3p | Carcinoma ductal breast | MNDR-E-MI-34027 |
MNDR | hsa-miR-28-3p | Glioblastoma | MNDR-E-MI-34028 |
MNDR | hsa-miR-28-3p | Malignant glioma | MNDR-E-MI-34029 |
MNDR | hsa-miR-28-3p | Chordoma | MNDR-E-MI-34030 |
MNDR | hsa-miR-28-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34031 |
MNDR | hsa-miR-28-3p | Osteosarcoma | MNDR-E-MI-34032 |
MNDR | hsa-miR-28-3p | Middle cerebral artery infarction | MNDR-E-MI-34033 |
MNDR | hsa-miR-28-3p | Gastric adenocarcinoma | MNDR-E-MI-34034 |
MNDR | hsa-miR-28-3p | Cervical squamous cell carcinoma | MNDR-E-MI-34035 |
MNDR | hsa-miR-28-3p | Lung squamous cell carcinoma | MNDR-E-MI-34036 |
MNDR | hsa-miR-28-3p | Lung adenocarcinoma | MNDR-E-MI-34037 |
MNDR | hsa-miR-28-3p | Thyroid carcinoma | MNDR-E-MI-34038 |
MNDR | hsa-miR-28-3p | Bladder urothelial carcinoma | MNDR-E-MI-34039 |
MNDR | hsa-miR-28-3p | Pancreatic adenocarcinoma | MNDR-E-MI-34040 |
MNDR | hsa-miR-28-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-34041 |
MNDR | hsa-miR-28-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34042 |
MNDR | hsa-miR-28-3p | Renal clear cell carcinoma | MNDR-E-MI-34043 |
MNDR | hsa-miR-28-3p | Cholangiocarcinoma | MNDR-E-MI-34044 |
MNDR | hsa-miR-28-3p | Esophageal cancer | MNDR-E-MI-34045 |
MNDR | hsa-miR-28-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-34046 |
MNDR | hsa-miR-28-3p | Breast invasive carcinoma | MNDR-E-MI-34047 |
MNDR | hsa-miR-28-3p | Hepatocellular carcinoma | MNDR-E-MI-34048 |
MNDR | hsa-miR-28-3p | Rheumatoid arthritis | MNDR-E-MI-34049 |
MNDR | hsa-miR-28-3p | Neuromyelitis optica | MNDR-E-MI-34050 |
MNDR | hsa-miR-28-3p | Colorectal cancer | MNDR-E-MI-34051 |
MNDR | hsa-miR-28-3p | Nasopharynx carcinoma | MNDR-E-MI-34052 |
MNDR | hsa-miR-28-3p | Multiple myeloma | MNDR-E-MI-34053 |
MNDR | hsa-miR-28-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-34054 |
MNDR | hsa-miR-28-3p | Nasopharyngeal cancer | MNDR-E-MI-34055 |
MNDR | hsa-miR-28-3p | Epstein-barr virus infections | MNDR-E-MI-34056 |
MNDR | hsa-miR-28-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-34057 |
MNDR | hsa-miR-28-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-34058 |
MNDR | hsa-miR-28-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-34059 |
MNDR | hsa-miR-28-3p | Peripheral nerve injuries | MNDR-E-MI-34060 |
MNDR | hsa-miR-28-3p | Chronic pain | MNDR-E-MI-34061 |
MNDR | hsa-miR-28-3p | Breast cancer her3+ negative | MNDR-E-MI-34062 |
MNDR | hsa-miR-28-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-34063 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | LINC02381 | Homo sapiens | RR00849535 |
TOP